Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial

Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

(2021) Yu-Pei Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial

(2021) Xing Lv et al.   LANCET ONCOLOGY

Testing for non-inferior mortality: a systematic review of non-inferiority margin sizes and trial characteristics

(2021) Sandra Pong et al.   BMJ Open

SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach

(2020) Pieter D. de Veij Mestdagh et al.   RADIOTHERAPY AND ONCOLOGY

Nasopharyngeal carcinoma

(2019) Yu-Pei Chen et al.   LANCET

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

(2018) Lin-Quan Tang et al.   LANCET ONCOLOGY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma

(2018) Rui Guo et al.   CANCER

Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes

(2018) F. Xiao et al.   Clinical & Translational Oncology

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

(2018) Hisham Mehanna et al.   LANCET

Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

(2017) Kiattisa Sommat et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era

(2017) Ling-Long Tang et al.   Journal of the National Comprehensive Cancer Network

The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement

(2017) Ling-Long Tang et al.   ORAL ONCOLOGY

Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neck

(2016) Lisa Licitra et al.   ORAL ONCOLOGY

A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma

(2013) Jin-Gao Li et al.   CANCER

Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy

(2013) Mo Chen et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: Which patients are at risk of significant quality-of-life deterioration?

(2013) Abrahim Al-Mamgani et al.   RADIOTHERAPY AND ONCOLOGY

Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines

(2013) Vincent Grégoire et al.   RADIOTHERAPY AND ONCOLOGY

Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation

(2012) Wen-Fei Li et al.   Chinese Journal of Cancer

Salvage Treatment for Isolated Regional Failure of Nasopharyngeal Carcinoma after Primary Radiotherapy

(2011) Wu-Chia Lo et al.   ANNALS OF SURGICAL ONCOLOGY

A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners

(2011) D.J. Fisher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?

(2010) Shu-Zhen Lai et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma

(2009) Linglong Tang et al.   CANCER

Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

(2009) Nancy Lee et al.   JOURNAL OF CLINICAL ONCOLOGY